Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery
Authors:
- Kathy S. AlbainKAKathy S. Albain
- Christina YauCYChristina Yau
- Emanuel F. PetricoinEPEmanuel F. Petricoin
- Denise M. WolfDWDenise M. Wolf
- Julie E. LangJLJulie E. Lang
- A. Jo ChienACA. Jo Chien
- Tufia HaddadTHTufia Haddad
- Andres Forero-TorresAFAndres Forero-Torres
- Anne M. WallaceAWAnne M. Wallace
- Henry KaplanHKHenry Kaplan
- Lajos PusztaiLPLajos Pusztai
- David EuhusDEDavid Euhus
Open Access
- 16 February 2024
- other
- Published by American Association for Cancer Research (AACR)